Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,434 | -280 | -2,501 | -1,637 | -11,852 |
| Depreciation Amortization | 390 | 272 | 154 | 57 | 234 |
| Accounts receivable | N/A | -500 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -19 | -45 | -74 | -11 | -348 |
| Other Working Capital | 17 | -266 | -49 | -44 | -903 |
| Other Operating Activity | 1,038 | 1,522 | 902 | 810 | 2,301 |
| Operating Cash Flow | $-8 | $703 | $-1,567 | $-824 | $-10,567 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -33 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-33 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,181 | 1,181 | 1,181 | N/A | N/A |
| Debt Repayment | -62 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5,828 | 871 | N/A | N/A | 9,255 |
| Other Financing Activity | 0 | -46 | -31 | -15 | -58 |
| Financing Cash Flow | $6,947 | $2,006 | $1,150 | $-15 | $9,198 |
| Beginning Cash Position | 1,243 | 1,243 | 1,243 | 1,243 | 2,646 |
| End Cash Position | 8,182 | 3,952 | 827 | 404 | 1,243 |
| Net Cash Flow | $6,938 | $2,709 | $-416 | $-839 | $-1,402 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8 | 703 | -1,567 | -824 | -10,567 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -33 |
| Free Cash Flow | -8 | 703 | -1,567 | -824 | -10,600 |